Search
AtriCure Inc
ATRCAdd to Watchlist
30.440USD
+0.710+2.39%
Market hours （ET）Quotes delayed by 15 min
1.52BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+2.54%
5 Days
+7.80%
1 Month
+15.12%
6 Months
-22.94%
Year to Date
-22.94%
1 Year
-5.33%
Key Figures
30.190Open
30.820High
245.74KVolume
LossP/E TTM
89.03P/E Dynamic
--Dividend TTM
0.49%Turnover Ratio
29.730Prev. Close
29.960Low
5.34MTurnover
LossP/E Static
3.08P/B
0.00%Div Yield TTM
-0.74%ROA
43.18052wk High
1.13Volume Ratio
-44.70MNet Profit
49.79MShares
-0.0952EPS TTM
1.27Beta
-0.97%ROE
25.52052wk Low
2.89%Amplitude
77.39%Gross Margin
1.52BMarket Cap
5.55Reward/Risk
2.69%Risk Rate
TradingKey Stock Score of AtriCure Inc
Currency: USD Updated: 2026-07-01Key Insights
AtriCure Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 22 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 49.38.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AtriCure Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
AtriCure Inc Highlights
StrengthsRisks
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.88% year-on-year.
Undervalued
The company’s latest PE is -312.42, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 48.18M shares, decreasing 12.70% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 43.35K shares of this stock.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
49.375
Target Price
+76.47%
Upside Space
AtriCure Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AtriCure Inc Info
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Ticker SymbolATRC
CompanyAtriCure Inc
CEOCarrel (Michael H)
Websitehttps://www.atricure.com
Related Instruments
+0.02%
+1.55%
+0.17%
+1.78%
+0.56%
-1.05%
+0.16%
+1.07%
+1.50%
+4.21%
+1.78%
+2.14%
+1.14%
+1.06%
+0.32%
+0.52%
+1.22%
-0.48%
-0.17%
-0.74%Popular Instruments
52704.900
+450.600 (+0.86%)
29849.900
+50.600 (+0.17%)
7525.400
+49.900 (+0.67%)
14846.000
-509.000 (-3.31%)
69066.000
-419.000 (-0.60%)
6374.200
+98.800 (+1.57%)
67.484
-0.484 (-0.71%)
303.365
+8.985 (+3.05%)
198.860
+1.280 (+0.65%)
4124.110
+93.340 (+2.32%)
FAQs
What is the current price of AtriCure Inc (ATRC)?
The current price of AtriCure Inc (ATRC) is 29.73.
What is the symbol of AtriCure Inc?
The ticker symbol of AtriCure Inc is ATRC.
What is the 52-week high of AtriCure Inc?
The 52-week high of AtriCure Inc is 43.18.
What is the 52-week low of AtriCure Inc?
The 52-week low of AtriCure Inc is 25.52.
What is the market capitalization of AtriCure Inc?
The market capitalization of AtriCure Inc is 1.51B.
Is AtriCure Inc (ATRC) currently rated as Buy, Hold, or Sell?
According to analysts, AtriCure Inc (ATRC) has an overall rating of Buy, with a price target of 49.38.
What is the Earnings Per Share (EPS TTM) of AtriCure Inc (ATRC)?
The Earnings Per Share (EPS TTM) of AtriCure Inc (ATRC) is -0.24.